Table 1.
Clinical and biochemical parameters of the study population
| Parameters | Values |
|---|---|
| Age (years) | 53.5 ± 5.7 |
| BMI (kg/m2) | 25.7 ± 3.4 |
| WC (cm) | 96.8 ± 10.1 |
| SBP (mmHg) | 120 (90–160) |
| DBP (mmHg) | 80 (60–100) |
| FPG (mg/dl) | 100.9 ± 11.8 |
| Insulin (mU/l) | 6.1 (1.2–28.7) |
| HoMA-IR | 1.4 (0.4–8.4) |
| Total cholesterol (mg/dl) | 208.1 ± 46.1 |
| HDL (mg/dl) | 49.8 ± 11.7 |
| LDL (mg/dl) | 129.8 ± 42.1 |
| TG (mg/dl) | 154.6 ± 73.6 |
| BPA (ng/ml) | 1.04 ± 0.77 |
| IL-6 (pg/ml) | 0.77 (0.06–3.43) |
| MCP-1 (pg/ml) | 27.4 ± 23.5 |
| TNFα (pg/ml) | 1.9 (0.5–9.1) |
Data are expressed as mean ± standard deviation or median, according to variable distribution. In particular, SBP, DBP, insulin, HoMA-IR, IL-6 and TNFα were expressed an median with range.
BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, HoMA-IR homeostasis model of assessment-insulin resistance, HDL high-density lipoprotein, LDL low-density lipoprotein, TG triglycerides, BPA bisphenol-A, IL-6 interleukin-6, MCP-1 monocyte chemoattractant protein-1, TNFα tumor necrosis factor-alpha.